Rafał Łunio

Rafał Łunio currently serves as Director of Research & Development and Qualified Person at Polfa Tarchomin S.A. since October 2021, where responsibilities include overseeing pharmaceutical research and development operations. Additionally, Rafał is the President of the AgeWell Foundation and an Expert Member of the European Directorate for the Quality of Medicines & HealthCare, contributing to regulatory standards for medicine quality in Europe. Prior experience includes over thirteen years at Polpharma, where Rafał held various roles, culminating as Head of Preformulation & Scientific Affairs, with a focus on interdisciplinary collaboration and project development. Rafał holds a PhD from the Medical University of Gdansk, specializing in pharmaceutical technology, following a Master’s degree in the same field from the same institution.